Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.

× No keyword cloud information.

18 in total

1. Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias.

Authors: Sunjeev K Kamboj; Alyssa Joye; Ravi K Das; Andrew J W Gibson; Celia J A Morgan; H Valerie Curran
Journal: Psychopharmacology (Berl) Date: 2011-11-22 Impact factor: 4.530

2. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.

Authors: Joseph O'Neill; Eda Gorbis; Jamie D Feusner; Jenny C Yip; Susanna Chang; Karron M Maidment; Jennifer G Levitt; Noriko Salamon; John M Ringman; Sanjaya Saxena
Journal: J Psychiatr Res Date: 2013-01-04 Impact factor: 4.791

Review 3. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors: Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal: Pharmacol Ther Date: 2011-09-22 Impact factor: 12.310

4. Changes in cue reactivity and attentional bias following experimental cue exposure and response prevention: a laboratory study of the effects of D-cycloserine in heavy drinkers.

Authors: Sunjeev K Kamboj; Rachel Massey-Chase; Lydia Rodney; Ravi Das; Basil Almahdi; H Valerie Curran; Celia J A Morgan
Journal: Psychopharmacology (Berl) Date: 2011-04-01 Impact factor: 4.530

5. Glutamatergic agents for OCD and related disorders.

Authors: Christopher Pittenger
Journal: Curr Treat Options Psychiatry Date: 2015-09

6. A trial of D-cycloserine to treat stereotypies in older adolescents and young adults with autism spectrum disorder.

Authors: Maria Urbano; Leonore Okwara; Paul Manser; Kathrin Hartmann; Amy Herndon; Stephen I Deutsch
Journal: Clin Neuropharmacol Date: 2014 May-Jun Impact factor: 1.592

Review 7. Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.

Authors: Joseph F McGuire; Adam B Lewin; Eric A Storch
Journal: Expert Rev Neurother Date: 2014-06-27 Impact factor: 4.618

8. Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers.

Authors: Jin H Yoon; Thomas F Newton; Colin N Haile; Patrick S Bordnick; Rachel E Fintzy; Chris Culbertson; James J Mahoney; Rollin Y Hawkins; Kathleen R LaBounty; Elizabeth L Ross; Adel I Aziziyeh; Richard De La Garza
Journal: Addict Behav Date: 2012-03-26 Impact factor: 3.913

Review 9. Challenges in developing novel treatments for childhood disorders: lessons from research on anxiety.

Authors: Daniel S Pine; Sarah M Helfinstein; Yair Bar-Haim; Eric Nelson; Nathan A Fox
Journal: Neuropsychopharmacology Date: 2008-08-27 Impact factor: 7.853

10. Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors: Jonathan T Ting; Guoping Feng
Journal: Curr Chem Genomics Date: 2008-01-01